Physician profile
Gerard T Eichman
NPI 1699774950
$15,870.57
in general payments reported to CMS, 2019-2025
55 companies · $2,240 in 2025
The $2,240 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,708 · 2020: $1,790 · 2021: $2,892 · 2022: $2,275 · 2023: $2,526 · 2024: $2,440 · 2025: $2,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,206.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,851.44 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Janssen Pharmaceuticals, INC | $1,775.95 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,201.99 | 2019-2025 | Watchman Flx, Watchman, Emblem Mri S-Icd |
| Merck Sharp & Dohme LLC | $1,028.32 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $904.81 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $860.69 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $682.67 | 2019-2020 | |
| Amgen INC. | $645.00 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $521.57 | 2021-2025 | Wegovy, Ozempic |
| Cvrx, INC. | $477.29 | 2021-2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $454.24 | 2021-2025 | Nexletol |
| Pfizer INC. | $448.76 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $422.53 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.86 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $375.82 | 2019-2021 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $252.47 | 2019-2022 | |
| Cleerly, INC. | $216.05 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Astrazeneca Pharmaceuticals LP | $205.57 | 2019-2025 | Farxiga |
| Edwards Lifesciences Corporation | $197.44 | 2022 | |
| W. L. Gore & Associates, INC. | $196.61 | 2021-2022 | |
| Bridgebio Pharma, INC. | $140.96 | 2025 | Attruby |
| Abbvie INC. | $125.00 | 2024 | |
| Atricure, INC. | $123.89 | 2020 | |
| Heartflow, INC. | $123.24 | 2022-2025 | Ffrct |
| Philips North America LLC | $115.98 | 2022-2025 | (Ck7) Extended Holter, Mcot, (Ck4) Mcot |
| Ancora Heart, INC. | $102.58 | 2022 | |
| Arbor Pharmaceuticals, INC. | $101.77 | 2020-2021 | |
| Irhythm Technologies, INC. | $74.72 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.33 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $67.76 | 2024-2025 | Optimizer |
| Gilead Sciences, INC. | $65.06 | 2019 | |
| Abbott Laboratories | $61.95 | 2021 | |
| Lundbeck LLC | $57.93 | 2019-2021 | |
| Medicomp INC | $55.03 | 2024-2025 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $46.95 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $40.93 | 2019-2025 | |
| Lilly USA, LLC | $32.65 | 2025 | Zepbound, Mounjaro |
| Bardy Diagnostics, INC. | $32.00 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $29.45 | 2021-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $26.59 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $26.17 | 2025 | Inspire |
| Molnlycke Health Care US, LLC | $26.17 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Recor Medical INC | $24.88 | 2024 | Paradise Renal Denervation System |
| Lantheus Medical Imaging, INC. | $20.09 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.97 | 2025 | |
| Glaxosmithkline, LLC. | $16.90 | 2025 | Arexvy, Shingrix |
| Azurity Pharmaceuticals, INC. | $16.83 | 2025 | Edarbi |
| Vivaquant INC, Dba Rhythm Express | $16.79 | 2025 | Rhythm Express |
| Medicure Pharma INC. | $15.63 | 2021 | |
| Optinose US, INC. | $14.24 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $14.15 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $14.01 | 2025 | |
| Phathom Pharmaceuticals, INC. | $12.12 | 2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $11.89 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $4.88 | 2024 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Eichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.